Recent Advances in the Diagnosis and Treatment of Presacral Tumours

Konstantinos Paschos, Evelina Tsiomita, Maria Sachanidou and Anestis Chatzigeorgiadis

Department of General Surgery, General Hospital of Drama, Greece

^*Correspondance to: Konstantinos Paschos 

 PDF  Full Text DOI: 10.25107/2474-1647.1496

Abstract

Presacral or retrorectal tumours (PST) s is rare lesions, which range from cysts (usually benign) to malignant masses, invading surrounding tissues in the pelvis. According to the tumour’s origin, characteristics and behavior, PSTs are classified as follows: congenital, neurogenic, osseous, miscellaneous, and inflammatory. They present variable signs and symptoms, a fact that may delay their diagnosis and/or cause an inappropriate treatment with bad prognosis. Nonetheless, modern imaging modalities, such as CT and MRI may discover the true nature of a lesion, as well as whether it infiltrates neighboring viscera. In that way, they substantially contribute to a definitive diagnosis and a correct preoperative planning. While neoadjuvant chemotherapy and postoperative radiotherapy may offer benefits in certain PSTs, surgical resection is the primary therapeutic management. The anterior, posterior and combined abdominosacral approach are applied, according to tumour location and its relation to adjacent structures. In general, clinicians should maintain high clinical suspicion of the disease to avoid delayed or false diagnosis. Multidisciplinary approach is crucial for a prompt and accurate treatment.

Keywords

Presacral; Retrorectal; Retroperitoneum; Rectum; Sacrum

Cite the article

Paschos K, Tsiomita E, Sachanidou M, Chatzigeorgiadis A. Recent Advances in the Diagnosis and Treatment of Presacral Tumours. Clin Surg. 2017; 2: 1496.